This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Ondansetron in pregnancy - risk of oral clefts (cleft palate)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Outside of its authorised indications, ondansetron is used second line for treating women with hyperemesis gravidarum - a severe and potentially life-threatening condition

  • if a physician considers, based on their professional judgement, the available evidence and the risks for mother and baby of malnutrition in early pregnancy, that a licensed treatment (for example doxylamine/pyridoxine) is not suitable or not sufficient alone to control severe nausea and vomiting in pregnancy, and there is a special clinical need to use ondansetron, then this decision should be made in consultation with the patient after she has been fully informed of the potential benefits and risks of the different treatment options (1)

  • study evidence reveals a small increased risk of orofacial malformations in babies born to women who used ondansetron in early pregnancy
    • an observational study of 1.8 million pregnancies in the USA of which 88,467 (4.9%) were exposed to oral ondansetron during the first trimester of pregnancy (2)
      • study reported that ondansetron use was associated with an additional 3 oral clefts per 10,000 births (14 cases per 10,000 births versus 11 cases per 10,000 births in the unexposed population)

Prescribers should refer to clinical guidance if treatment with ondansetron is considered for severe nausea and vomiting in pregnancy (3).

Reference:


Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.